User menu

Study of the HIV-2 Env cytoplasmic tail variability and its impact on Tat, Rev and Nef

Bibliographic reference Bakouche, Nordine ; Vandenbroucke, Anne-Thérèse ; Goubau, Patrick ; Ruelle, Jean. Study of the HIV-2 Env cytoplasmic tail variability and its impact on Tat, Rev and Nef. In: PLoS One, Vol. 8, no.11, p. e79129 [1-14] (2013)
Permanent URL
  1. Checkley Mary Ann, Luttge Benjamin G., Freed Eric O., HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation, 10.1016/j.jmb.2011.04.042
  2. Hallenberger Sabine, Bosch Valerie, Angliker Herbert, Shaw Elliott, Klenk Hans-Dieter, Garten Wolfgang, Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60, 10.1038/360358a0
  3. Bosch M., Earl P., Fargnoli K, Picciafuoco S, Giombini F, Wong-Staal F, Franchini G, Identification of the fusion peptide of primate immunodeficiency viruses, 10.1126/science.2541505
  4. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C., Atomic structure of the ectodomain from HIV-1 gp41, 10.1038/387426a0
  5. Tan K., Liu J.-h., Wang J.-h., Shen S., Lu M., Atomic structure of a thermostable subdomain of HIV-1 gp41, 10.1073/pnas.94.23.12303
  6. Shang L., Yue L., Hunter E., Role of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein in Cell-Cell Fusion and Virus Infection, 10.1128/jvi.02666-07
  7. JF Rowell, J Immunol, 155, 473 (1995)
  8. Ohno Hiroshi, Aguilar Ruben C, Fournier Marie-Christine, Hennecke Silke, Cosson Pierre, Bonifacino Juan S, Interaction of Endocytic Signals from the HIV-1 Envelope Glycoprotein Complex with Members of the Adaptor Medium Chain Family, 10.1006/viro.1997.8839
  9. Boge Michael, Wyss Stéphanie, Bonifacino Juan S., Thali Markus, A Membrane-proximal Tyrosine-based Signal Mediates Internalization of the HIV-1 Envelope Glycoprotein via Interaction with the AP-2 Clathrin Adaptor, 10.1074/jbc.273.25.15773
  10. Byland R., Vance P. J., Hoxie J. A., Marsh M., A Conserved Dileucine Motif Mediates Clathrin and AP-2-dependent Endocytosis of the HIV-1 Envelope Protein, 10.1091/mbc.e06-06-0535
  11. Wyss S., Berlioz-Torrent C., Boge M., Blot G., Honing S., Benarous R., Thali M., The Highly Conserved C-Terminal Dileucine Motif in the Cytosolic Domain of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Is Critical for Its Association with the AP-1 Clathrin Adapter, 10.1128/jvi.75.6.2982-2992.2001
  12. Kennedy R., Henkel R., Pauletti D, Allan J., Lee T., Essex M, Dreesman G., Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein, 10.1126/science.3006246
  13. TC Chanh, EMBO J, 5, 3065 (1986)
  14. Cleveland S. M., A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion, 10.1099/vir.0.18630-0
  15. MILLER MARK A., GARRY ROBERT F., JAYNES JESSE M., MONTELARO RONALD C., A Structural Correlation Between Lentivirus Transmembrane Proteins and Natural Cytolytic Peptides, 10.1089/aid.1991.7.511
  16. Miller Mark A., Cloyd Miles W., Liebmann James, Rinaldo Charles R., Islam Kazi R., Wang Sherry Z.S., Mietzner Timothy A., Montelaro Ronald C., Alterations in Cell Membrane Permeability by the Lentivirus Lytic Peptide (LLP-1) of HIV-1 Transmembrane Protein, 10.1006/viro.1993.1457
  17. Eisenberg David, Wesson Morgan, The most highly amphiphilic ?-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41, 10.1002/bip.360290122
  18. VENABLE RICHARD M., PASTOR RICHARD W., BROOKS BERNARD R., CARSON FREDERICK W., Theoretically Determined Three-Dimensional Structures for Amphipathic Segments of the HIV-1 gp41 Envelope Protein, 10.1089/aid.1989.5.7
  19. Noble B., Abada P., Nunez-Iglesias J., Cannon P. M., Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release, 10.1128/jvi.80.6.2924-2932.2006
  20. YM Naidu, J Virol, 62, 4691 (1988)
  21. Schmitt Armin O., Herzel Hanspeter, Estimating the Entropy of DNA Sequences, 10.1006/jtbi.1997.0493
  22. Postler Thomas S., Desrosiers Ronald C., The Cytoplasmic Domain of the HIV-1 Glycoprotein gp41 Induces NF-κB Activation through TGF-β-Activated Kinase 1, 10.1016/j.chom.2011.12.005
  23. PJ Dillon, J Virol, 64, 4428 (1990)
  24. Waheed Abdul A., Ablan Sherimay D., Mankowski Marie K., Cummins James E., Ptak Roger G., Schaffner Carl P., Freed Eric O., Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester : SELECTION FOR RESISTANT VARIANTS, 10.1074/jbc.m603609200
  25. Waheed A. A., Ablan S. D., Roser J. D., Sowder R. C., Schaffner C. P., Chertova E., Freed E. O., HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease, 10.1073/pnas.0701443104
  26. Waheed A. A., Ablan S. D., Sowder R. C., Roser J. D., Schaffner C. P., Chertova E., Freed E. O., Effect of Mutations in the Human Immunodeficiency Virus Type 1 Protease on Cleavage of the gp41 Cytoplasmic Tail, 10.1128/jvi.02002-09
  27. LEE SHU-JAN, HU W., FISHER AMANDA G., LOONEY DAVID J., KAO VIVIAN F., MITSUYA HIROAKI, RATNER LEE, WONG-STAAL FLOSSIE, Role of the Carboxy-Terminal Portion of the HIV-1 Transmembrane Protein in Viral Transmission and Cytopathogenicity, 10.1089/aid.1989.5.441
  28. Wilk Thomas, Pfeiffer Tanya, Bosch Valerie, Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product, 10.1016/0042-6822(92)90692-i
  29. DH Gabuzda, J Virol, 66, 3306 (1992)
  30. X Yu, J Virol, 67, 213 (1993)
  31. EO Freed, J Virol, 69, 1984 (1995)
  32. EO Freed, J Virol, 70, 341 (1996)
  33. Murakami T., Freed E. O., Genetic Evidence for an Interaction between Human Immunodeficiency Virus Type 1 Matrix and alpha -Helix 2 of the gp41 Cytoplasmic Tail, 10.1128/jvi.74.8.3548-3554.2000
  34. V Kalia, J Virol, 77, 3634 (2003)
  35. Affranchino José L., González Silvia A., Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions, 10.1016/j.virol.2005.11.032
  36. Kalia V., Sarkar S., Gupta P., Montelaro R. C., Rational Site-Directed Mutations of the LLP-1 and LLP-2 Lentivirus Lytic Peptide Domains in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41 Indicate Common Functions in Cell-Cell Fusion but Distinct Roles in Virion Envelope Incorporation, 10.1128/jvi.77.6.3634-3646.2003
  37. Newman Jason T., Sturgeon Timothy J., Gupta Phalguni, Montelaro Ronald C., Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain, 10.1016/j.virol.2007.05.027
  38. Hye Sung, Soon Ah Shin, Hae Kyung P Ji, Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells, 10.1080/135502801753170318
  39. Yang P., Ai L.-S., Huang S.-C., Li H.-F., Chan W.-E., Chang C.-W., Ko C.-Y., Chen S. S.-L., The Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 Harbors Lipid Raft Association Determinants, 10.1128/jvi.00899-09
  40. CP Spies, J Virol, 68, 585 (1994)
  41. Edwards T. G., Wyss S., Reeves J. D., Zolla-Pazner S., Hoxie J. A., Doms R. W., Baribaud F., Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein, 10.1128/jvi.76.6.2683-2691.2002
  42. Kalia V., Sarkar S., Gupta P., Montelaro R. C., Antibody Neutralization Escape Mediated by Point Mutations in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41, 10.1128/jvi.79.4.2097-2107.2005
  43. Steckbeck Jonathan D., Craigo Jodi K., Barnes Christopher O., Montelaro Ronald C., Highly Conserved Structural Properties of the C-terminal Tail of HIV-1 gp41 Protein Despite Substantial Sequence Variation among Diverse Clades : IMPLICATIONS FOR FUNCTIONS IN VIRAL REPLICATION, 10.1074/jbc.m111.258855
  44. Lu Lu, Zhu Yun, Huang Jinghe, Chen Xi, Yang Hengwen, Jiang Shibo, Chen Ying-Hua, Surface Exposure of the HIV-1 Env Cytoplasmic Tail LLP2 Domain during the Membrane Fusion Process : INTERACTION WITH gp41 FUSION CORE, 10.1074/jbc.m801083200
  45. Jeang Kuan-Teh, Xiao Hua, Rich Elizabeth A., Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat, 10.1074/jbc.274.41.28837
  46. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M., Santos-Ferreira M., Laurent A., Dauguet C, Katlama C, Rouzioux C, al. e., Isolation of a new human retrovirus from West African patients with AIDS, 10.1126/science.2425430
  47. Rey Marie-Anne, Krust Bernard, Laurent Anne G., Guétard Denise, Montagnier Luc, Hovanessian Ara G., Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein, 10.1016/0042-6822(89)90242-0
  48. Mann Dean L., O'Brien Stephen J., Gilbert Dennis A., Reid Yvonne, Popovic Mikulas, Read-Connole Elizabeth, Gallo Robert C., Gazdar Adi F., Origin of the HIV-Susceptible Human CD4+ Cell Line H9, 10.1089/aid.1989.5.253
  49. Popovic Mikulas, Read-Connole Elizabeth, Gallo RobertC., T4 POSITIVE HUMAN NEOPLASTIC CELL LINES SUSCEPTIBLE TO AND PERMISSIVE FOR HTLV-III, 10.1016/s0140-6736(84)91666-0
  50. Popovic M, Sarngadharan M., Read E, Gallo R., Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS, 10.1126/science.6200935
  51. Ribeiro A. C., Maia e Silva A., Santa-Marta M., Pombo A., Moniz-Pereira J., Goncalves J., Barahona I., Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G, 10.1128/jvi.79.2.823-833.2005
  52. Graham F. L., Russell W. C., Smiley J., Nairn R., Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, 10.1099/0022-1317-36-1-59
  53. T Haertle, J Biol Chem, 263, 5870 (1988)
  54. S Harada, Science, 229, 563 (1985)
  55. Harada S, Koyanagi Y, Yamamoto N, Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay, 10.1126/science.2992081
  56. Larder B., Darby G, Richman D., HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy, 10.1126/science.2467383
  57. Pauwels Rudi, De Clercq Erik, Desmyter Jan, Balzarini Jan, Goubau Patrick, Herdewijn Piet, Vanderhaeghe Hubert, Vandeputte Michel, Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus, 10.1016/0166-0934(87)90002-4
  58. Multalin
  59. Transeq
  60. Kyte